Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin versus liraglutide versus combination therapy for weight loss in overweight women with polycystic ovary syndrome
ChiCTR1800017538Phase 4Recruiting
- Sponsor
- Union Hospital
- Start
- Aug 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in polycystic ovary syndrome (PCOS) comparing Glucophage monotherapy, Liraglutide monotherapy and Glucophage + liraglutide (3 arms). Primary endpoint: Weight. Started Aug 2018; status: recruiting.
02
Drugs
metforminliraglutide
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR1800017538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017538.